Other Events ·
Nasdaq confirms Rockwell Medical has regained compliance with the $1.00 minimum bid price requirement
RMTIRockwell Medical, Inc.
Rockwell Medical, Inc. received written notification from Nasdaq on July 16, 2026, confirming the company has regained compliance with the minimum $1.00 per share bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company maintained a minimum closing bid price of $1.00 or greater between July 1, 2026, and July 15, 2026, resulting Nasdaq to consider the compliance matter closed. Rockwell Medical is now in full compliance with all Nasdaq continued listing requirements. Rockwell Medical is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products.